BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cidon EU. New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future. World J Gastrointest Oncol 2017; 9(1): 4-20 [PMID: 28144395 DOI: 10.4251/wjgo.v9.i1.4]
URL: https://www.wjgnet.com/1007-9327/full/v9/i1/4.htm
Number Citing Articles
1
Parthik Patel, Karina Galoian. Molecular challenges of neuroendocrine tumors (Review)Oncology Letters 2017;  doi: 10.3892/ol.2017.7680
2
Leonidas N. Diamantopoulos, Markos Kalligeros, Thorvardur R. Halfdanarson, Nikolaos Diamantis, Christos Toumpanakis. Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective StudiesBiology 2023; 12(8): 1069 doi: 10.3390/biology12081069
3
Erica B. Sneider, Justin A. Maykel. Comprehensive Rectal Cancer Care2019; : 575 doi: 10.1007/978-3-319-98902-0_30
4
Aurelio Negro, Giovanni M. Rossi, Davide Nicoli, Annibale Versari, Enrico Farnetti, Rosaria Santi, Stefano De Pietri. Peptide Receptor Radionuclide Therapy–Induced Gitelman-like SyndromeAmerican Journal of Kidney Diseases 2017; 70(5): 725 doi: 10.1053/j.ajkd.2017.05.024
5
Steven D. Colquhoun. Neuroendocrine tumors with hepatic metastases: A review of evolving treatment optionsLiver Research 2018; 2(2): 92 doi: 10.1016/j.livres.2018.08.002
6
Marialuisa Appetecchia, Rosa Lauretta, Francesca Rota, Massimo Carlini. Abdominal Neuroendocrine TumorsUpdates in Surgery 2018; : 53 doi: 10.1007/978-88-470-3955-1_4
7
Faidon-Marios Laskaratos, Martyn Caplin. Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumoursEuropean Journal of Surgical Oncology 2019; 45(1): 52 doi: 10.1016/j.ejso.2018.03.012
8
Marta Benavent, Javier Sastre, Ignacio García Escobar, Angel Segura, Jaume Capdevila, Alberto Carmona, Isabel Sevilla, Teresa Alonso, Guillermo Crespo, Lourdes García, Neus Canal, Guillermo de la Cruz, Javier Gallego. Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS)Health and Quality of Life Outcomes 2021; 19(1) doi: 10.1186/s12955-021-01688-x
9
Georgios S. Limouris. Liver Intra-arterial PRRT with 111In-Octreotide2021; : 75 doi: 10.1007/978-3-030-70773-6_6
10
Tiina Vesterinen, Helena Leijon, Harri Mustonen, Satu Remes, Aija Knuuttila, Kaisa Salmenkivi, Paula Vainio, Johanna Arola, Caj Haglund. Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid TumorsThe Journal of Clinical Endocrinology & Metabolism 2019; 104(6): 2083 doi: 10.1210/jc.2018-01931
11
Feng Yin, Zi-Hao Wu, Jin-Ping Lai. New insights in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasmsWorld Journal of Gastroenterology 2022; 28(17): 1751-1767 doi: 10.3748/wjg.v28.i17.1751